Konecranes Plc (KCR)
Helsinki Exchange · Finland · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 28.66 |
|---|---|
| 52-week range | 23.03 – 34.57 |
| Return, 1 month / 3 months | −4.9% / +0.5% |
| Return, 1 year / 3 years | +32.2% / +220.0% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 40.2% |
| Worst drawdown (1 year) | -20.1% |
| Average daily value traded | 9.16M EUR |
| Dividend yield | 23.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Konecranes Plc is a Finnish engineering company that makes lifting equipment and provides related services. Its products include overhead cranes, hoists and lifting systems used in factories and workshops, along with container-handling machinery such as ship-to-shore cranes and straddle carriers for port terminals. The company also offers maintenance, inspection and modernisation services for lifting equipment. Customers include manufacturers, industrial plants, ports and other businesses that move heavy loads, and the company is based in Finland.
On this site Konecranes Plc appears as a stock on the Helsinki Exchange (Finland), code KCR, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Konecranes Plc (KCR) trades on the Helsinki Exchange in Finland. It last closed at EUR 28.66 on 22 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 50 of 190 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 32.2% and over the last three months it rose 0.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Helsinki Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -0.1% | ||
| From 52-week high | -17.1% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.5% | ||
| 6-month return | -6.1% | ||
| 12-month return, skipping the last month | 39.1% | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 40.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.1% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 9.16M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 80 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 23.6% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −3.6% |
|---|---|
| 1 month | −4.9% |
| 3 months | +0.5% |
| 6 months | −6.1% |
| 1 year | +32.2% |
| 3 years | +220.0% |
| 5 years | +191.7% |
Signals
| 50-day / 200-day average | 29.64 / 28.69 |
|---|---|
| Golden / death cross (60 days) | Golden, 19 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.80 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Mar 2026 | EUR 6.7500 |
| 28 Mar 2025 | EUR 1.6500 |
| 28 Mar 2024 | EUR 1.3500 |
| 30 Mar 2023 | EUR 1.2500 |
| 16 Jun 2022 | EUR 1.2500 |
| 31 Mar 2021 | EUR 0.8800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Helsinki Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.